Overexpression of H-Ryk in mouse fibroblasts confers transforming ability in vitro and in vivo: Correlation with up-regulation in epithelial ovarian cancer
Rmt. Katso et al., Overexpression of H-Ryk in mouse fibroblasts confers transforming ability in vitro and in vivo: Correlation with up-regulation in epithelial ovarian cancer, CANCER RES, 59(10), 1999, pp. 2265-2270
Abnormalities in the function of receptor tyrosine kinases (RTKs) have been
demonstrated to be important in the pathogenesis of cancer. H-Ryk, a new m
ember of the RTK family, is an unusual RTK in that it is catalytically inac
tive because of amino acid substitutions of conserved residues in the catal
ytic domain. We show by immunohistochemistry that it is expressed in the ep
ithelium, stroma, and blood vessels of normal tissues, Evaluation of a pane
l of 33 primary ovarian tumors (2 benign, 8 borderline, and 23 malignant) w
as performed. H-Ryk was overexpressed in borderline and malignant ovarian t
umors. In serous and clear cell subtypes, there was increased expression in
the epithelium, stroma, and blood vessels. Consistent with this observatio
n, overexpression of H-Ryk in the mouse fibroblast cell line NIH3T3 induces
anchorage-independent growth and tumorigenicity in nude mice. This implies
that overexpression of the receptor can be transforming and may therefore
be significant in the pathogenesis of ovarian cancer.